PROK
ProKidney Corp.
1W: -12.0%
1M: -18.3%
3M: -25.6%
YTD: -17.9%
1Y: +79.4%
3Y: -81.5%
$1.83
+0.04 (+2.23%)
After Hours: $1.71 (-0.12, -6.28%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$10.3M
Congress—
ETF Holdings—
Key Statistics
Market Cap$529.8M
52W Range0.46-7.13
Volume810,608
Avg Volume847,120
Beta1.80
Dividend—
Analyst Ratings
Company Info
CEOBruce Culleton
Employees204
SectorHealthcare
IndustryBiotechnology
IPO Date2021-06-30
Websiteprokidney.com
2000 Frontis Plaza Blvd.
Winston-Salem, NC 27103
US
Winston-Salem, NC 27103
US
336 999 7028
About ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Latest News
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
Q2 Earnings Forecast for ProKidney Issued By HC Wainwright
ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Q1 Earnings Forecast for ProKidney Issued By HC Wainwright
ProKidney GAAP EPS of -$0.52 beats by $0.18, revenue of $0.89M beats by $0.35M
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Coulston James | A-Award | 600,000 | $2.24 | 2026-03-01 |
| Weber Darin J. | A-Award | 400,000 | $2.24 | 2026-03-01 |
| Girolamo Todd C | A-Award | 600,000 | $2.24 | 2026-03-01 |
| Culleton Bruce | A-Award | 3,000,000 | $2.24 | 2026-03-01 |
| Pereira Brian JG | S-Sale | 54,333 | $2.37 | 2025-11-13 |